Laboratory Workup for Fatigue
The laboratory evaluation for fatigue should be selective and guided by symptom severity, clinical context, and associated symptoms rather than reflexive ordering of extensive testing. 1
Initial Severity Assessment
- Quantify fatigue using a 0-10 numeric rating scale before ordering any laboratory tests 2, 1
- Scores 1-3: mild fatigue
- Scores 4-6: moderate fatigue
- Scores 7-10: severe fatigue
- Laboratory testing is indicated primarily when fatigue scores ≥4 and should be based on the presence of other symptoms, onset pattern, and severity 2, 1
Core Laboratory Panel (When Indicated)
Complete Blood Count with Differential
- Measure hemoglobin/hematocrit to screen for anemia as a treatable cause of fatigue 2, 1
- Compare current values with any prior baseline measurements (particularly relevant in cancer survivors) 2
- Assess white blood cell count and platelet count to evaluate other hematologic abnormalities 2, 1
Comprehensive Metabolic Panel
- Assess electrolyte levels (sodium, potassium, chloride, bicarbonate) to identify disturbances contributing to fatigue 2, 1
- Evaluate hepatic function through liver enzymes and bilirubin 2, 1
- Assess renal function via creatinine and blood urea nitrogen 2, 1
- Measure fasting blood glucose to screen for dysglycemia 1
Thyroid Function Testing
- Measure thyroid-stimulating hormone (TSH) as the primary screening test for thyroid dysfunction 2, 1
- Reserve more comprehensive endocrine evaluation or specialist referral for patients with additional symptoms suggesting specific disorders (hypothyroidism, hypogonadism, adrenal insufficiency, hypopituitarism—especially in patients on immunotherapy) 2, 1
Context-Specific Additional Testing
When Urinary or Metabolic Concerns Present
- Perform urinalysis (protein, blood, glucose) if urinary symptoms or metabolic abnormalities are suspected 2, 1
When Inflammatory Conditions Suspected
- Consider inflammatory markers (erythrocyte sedimentation rate, C-reactive protein) when clinical features suggest an inflammatory process 2, 1
For Patients on Immunotherapy
- In patients treated with immune checkpoint inhibitors presenting with new or worsening fatigue, the Society for Immunotherapy of Cancer recommends: CBC, comprehensive metabolic panel, TSH, free thyroxine, morning cortisol, and adrenocorticotropic hormone to evaluate for immune-related adverse events 2
Critical Non-Laboratory Assessment Components
Laboratory testing alone is insufficient and must be accompanied by systematic evaluation of other treatable contributors:
- Review all current medications for fatigue-inducing effects, particularly sleep aids, analgesics, and antiemetics 2, 1
- Screen for alcohol and substance use that may contribute to fatigue 2, 1
- Evaluate nutritional status and recent weight changes 2, 1
- Assess sleep quality and disturbances (insomnia, sleep apnea, vasomotor symptoms) 2, 1
- Screen for emotional distress, depression, and anxiety using validated tools, as these are frequent contributors 2, 1
- Evaluate functional status and activity level to contextualize fatigue severity 2, 1
Important Caveats
The yield of extensive laboratory testing in chronic fatigue is low. Research demonstrates that physical examinations produce diagnostic information in only 2% of patients and laboratory investigations elucidate the cause in only 5% of patients with chronic fatigue 3. Minor laboratory abnormalities are relatively common but often do not contribute meaningfully to diagnosis or influence clinical outcomes 4, 3.
Psychological factors are frequently underrecognized. Studies show that patients with chronic fatigue lasting >1 year often have significant psychological symptoms, with evaluation focusing on psychological causes being more productive than extensive laboratory workups 4. However, this does not negate the importance of ruling out treatable organic causes through the focused laboratory panel described above.
The decision to order laboratory tests should be clinical judgment-based rather than reflexive, considering the pattern of fatigue onset, associated symptoms, and severity 2, 1. This approach balances the need to identify treatable organic causes while avoiding unnecessary testing with low diagnostic yield.